[8c54ae]: / data / outputs_small / 2a19ac8c-076b-857f-48f9-5776d28cd7f8_eligibility.json

Download this file

188 lines (188 with data), 5.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
{
"patientId": "2a19ac8c-076b-857f-48f9-5776d28cd7f8",
"eligibleTrials": [
{
"trialId": "NCT06576986",
"studyTitle": "Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy",
"eligibilityCriteriaMet": [
"Condition",
"Age",
"Gender",
"Condition/Medication",
"Treatment",
"Location",
"Consent",
"Medication"
]
},
{
"trialId": "NCT06576700",
"studyTitle": "Effect of Procyanidins in Leaky Gut Repairing in IBD",
"eligibilityCriteriaMet": [
"Diagnosis",
"Disease Status",
"Age",
"Participation Ability",
"Infection Status",
"Pregnancy Status",
"Medication Status"
]
},
{
"trialId": "NCT06577025",
"studyTitle": "A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",
"eligibilityCriteriaMet": [
"Diagnosis",
"Stage",
"Fitness",
"Measurable Disease",
"Performance Status",
"Malignancy",
"Neuropathy",
"CNS Involvement",
"Stroke/Seizure",
"Plasma Cell Leukemia",
"High-Risk Disease Features",
"HIV Status"
]
},
{
"trialId": "NCT06576895",
"studyTitle": "Nutrition Practice in Critically Ill Adults - an Observational Study",
"eligibilityCriteriaMet": [
"Age",
"Admission Status",
"Duration of Stay",
"Discharge Status",
"Care Type"
]
},
{
"trialId": "NCT06576986",
"studyTitle": "Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy",
"eligibilityCriteriaMet": [
"Condition",
"Age",
"Gender",
"Condition/Protocol",
"Condition/Treatment",
"Location",
"Consent",
"Medication History",
"Pregnancy Status"
]
},
{
"trialId": "NCT06577025",
"studyTitle": "A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",
"eligibilityCriteriaMet": [
"Diagnosis",
"Stage",
"Fitness",
"Measurable Disease",
"Performance Status",
"Malignancy",
"Neuropathy",
"CNS Involvement",
"Stroke/Seizure",
"Disease Features",
"HIV Status"
]
},
{
"trialId": "NCT06576895",
"studyTitle": "Nutrition Practice in Critically Ill Adults - an Observational Study",
"eligibilityCriteriaMet": [
"Age",
"Admission Status",
"Duration of Stay",
"Discharge Status",
"Care Type"
]
},
{
"trialId": "NCT06576986",
"studyTitle": "Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy",
"eligibilityCriteriaMet": [
"Condition",
"Age",
"Gender",
"Condition/Protocol",
"Treatment",
"Location",
"Consent",
"Medication",
"Pregnancy/Breastfeeding"
]
},
{
"trialId": "NCT06576700",
"studyTitle": "Effect of Procyanidins in Leaky Gut Repairing in IBD",
"eligibilityCriteriaMet": [
"Diagnosis",
"Disease Status",
"Age",
"Participation Ability",
"Infection Status",
"Pregnancy Status",
"Medication Status"
]
},
{
"trialId": "NCT06577025",
"studyTitle": "A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",
"eligibilityCriteriaMet": [
"Diagnosis",
"Stage",
"Fitness",
"Measurable Disease",
"Performance Status",
"Malignancy",
"Neuropathy",
"CNS Involvement",
"Stroke/Seizure",
"Plasma Cell Leukemia",
"High-Risk Disease Features",
"HIV Status"
]
},
{
"trialId": "NCT06576323",
"studyTitle": "An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)",
"eligibilityCriteriaMet": [
"Profession (Healthcare Provider)",
"Relationship (Biological Mother)",
"Mental Health (Active Suicidal Ideation)",
"Age (18 Years and older)",
"Sex (All)",
"Healthy Volunteers (Accepts Healthy Volunteers)"
]
},
{
"trialId": "NCT06576895",
"studyTitle": "Nutrition Practice in Critically Ill Adults - an Observational Study",
"eligibilityCriteriaMet": [
"Age",
"Admission Status",
"Duration of Stay",
"Discharge Status",
"Care Type"
]
},
{
"trialId": "NCT06576986",
"studyTitle": "Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy",
"eligibilityCriteriaMet": [
"Condition",
"Age",
"Gender",
"Condition/Protocol",
"Condition/Treatment",
"Location",
"Consent",
"Medication History",
"Pregnancy Status"
]
}
]
}